| Literature DB >> 34045808 |
Sara Saeidi1, Bita Dadpour1, Lida Jarahi2, Anahita A Ghamsari1, Mahdi J Nooghabi3.
Abstract
BACKGROUND: Botulism occurs periodically or in outbreaks in Iran. Botulism is lethal and accordingly a considerable issue in environmental health, although it is uncommon. This study was performed to evaluate the potential predictive factors in foodborne botulism in a 10-year span.Entities:
Keywords: Botulism; Clinical toxicology; Foodborne; Predictive; Prognostic factors
Year: 2021 PMID: 34045808 PMCID: PMC8138651 DOI: 10.5005/jp-journals-10071-23777
Source DB: PubMed Journal: Indian J Crit Care Med ISSN: 0972-5229
Clinical and demographic characteristics and associated mortality
| Age (mean ± SD, Min–Max) | 28.93 ± 19.14 (1–71) | 0.232 |
| Sex | ||
| Male | 28 (45.9%) | 0.325 |
| Female | 33 (54.1%) | |
| Contaminated foods | ||
| Leftovers | 22 (36.1%) | 0.316 |
| Yogurt and kashk | 7 (11.5%) | |
| Meat and tuna | 15 (24.6%) | |
| Canned beans | 9 (14.8%) | |
| Olivier and pasta salad | 8 (13.1%) | |
| Homemade foods | 16 (26.2%) | 0.999 |
| Length of hospital | 6.65 ± 8.85 (1–51) | 0.412 |
| Stay (day) (mean ± SD, min–max) | ||
| Need for ICU admission | 17 (27.9%) | 0.062 |
| Need for mechanical ventilation | 3 (5%) | 0.010 |
| Length of ICU | 2.12 ± 6.66 (0–47) | 0.058 |
| Stay (day) (mean ± SD, min–max) | ||
| Antitoxin dose | 3.35 ± 3.36 (1–17) | 0.275 |
| Polyvalent | ||
| Antitoxin (n) (mean ± SD, min–max) | ||
| Time elapsed between onset of symptoms and antitoxin (day) | 4.78 ± 3.58 (less than 24 to 14 h) | 0.259 |
| Mortality rate (%) | 4(6.6%) |
Pearson's correlation and chi-square test were used
Clinical manifestations and associated mortality
| Diplopia | 42 (68.9%) | 4.91 | 0.999 | 0.722 | 0.070 | 7.431 |
| Dysphagia | 36 (59%) | 3.27 | 0.999 | 1.478 | 0.194 | 11.257 |
| Ptosis | 34 (55.7%) | 4.91 | 0.623 | 0.397 | 0.039 | 4.054 |
| General weakness | 29 (47.5%) | 6.55 | 0.046 | |||
| Blurred vision | 23 (37.7%) | 1.63 | 0.999 | 1.886 | 0.184 | 19.287 |
| Dyspnea | 16 (26.2%) | 3.27 | 0.279 | 0.326 | 0.042 | 2.531 |
| Decreased muscle tone | 15 (24.6%) | 3.27 | 0.251 | 0.295 | 0.038 | 2.307 |
| Dizziness | 15 (24.6%) | 0 | 0.564 | |||
| Mydriasis | 13 (21.3%) | 3.27 | 0.196 | 0.239 | 0.030 | 1.890 |
| Nasal speech | 10 (16.4%) | 3.27 | 0.122 | 0.163 | 0.020 | 1.330 |
| Nausea vomiting | 8 (13.1%) | 0 | 0.999 | |||
| Lack of consciousness | 7 (11.5%) | 3.27 | 0.061 | 0.096 | 0.011 | 0.837 |
| Drooling | 6 (9.8%) | 1.63 | 0.346 | 0.288 | 0.025 | 3.317 |
| Constipation | 5 (8.2%) | 0 | 0.999 | |||
Chi-square test was used
Logistic binary regression model (enter mode) of all variables
| Sex | 0.227 | 0.00 |
| Age | 0.233 | 1.033 |
| Hospital stay | 0.783 | 0.223 |
| Period time between manifestation of symptoms and receiving antitoxin | 0.548 | 0.023 |
| ICU admission | 0.030 | 0.061 |
| Need for ventilation | 0.000 | 1.183 |
| Dysphagia | 0.704 | 0.00 |
| Dyspnea | 0.264 | 0.465 |
| General weakness | 0.030 | 1.542 |
| Decreased muscle tone | 0.222 | 0.520 |
| Drooling | 0.292 | 0.00 |
| Diplopia | 0.784 | 0.841 |
| Blurred vision | 0.588 | 0.130 |
| Ptosis | 0.422 | 0.011 |
| Mydriasis | 0.147 | 0.00 |
| Dizziness | 0.237 | 0.068 |
| Nausea vomiting | 0.421 | 0.00 |
| Lack of consciousness | 0.012 | 1.616 |
| Overall statistics | 0.008 | 0.070 |